Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.

<h4>Background</h4>The RTS,S/ASO1E malaria vaccine is being piloted in three countries-Ghana, Kenya, and Malawi-as part of a coordinated evaluation led by the World Health Organization, with support from global partners. This study estimates the costs of continuing malaria vaccination up...

Full description

Bibliographic Details
Main Authors:	Ranju Baral, Ann Levin, Chris Odero, Clint Pecenka, Collins Tabu, Evans Mwendo, George Bonsu, John Bawa, John Frederick Dadzie, Joyce Charo, Kwadwo Odei Antwi-Agyei, Kwame Amponsa-Achianou, Rose Eddah Jalango, Rouden Mkisi, Scott Gordon, Temwa Mzengeza, Winthrop Morgan, Farzana Muhib
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0244995

Similar Items

RTS,S Malaria Vaccine and Increased Mortality in Girls
by: Sabra L. Klein, et al.
Published: (2016-05-01)

The Costs of Implementing Vaccination With the RTS,S Malaria Vaccine in Five Sub-Saharan African Countries
by: Elisa Sicuri, et al.
Published: (2019-12-01)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
by: Juliette Fortpied, et al.
Published: (2020-06-01)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
by: Roly Gosling, et al.
Published: (2016-04-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
by: Griffin J. Bell, et al.
Published: (2020-06-01)

Clinical development of RTS,S as a vaccine for the prevention of malaria in Mozambican children
by: Sacarlal, Jahit
Published: (2009)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
by: Ismaila Thera, et al.
Published: (2020-09-01)

Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
by: Alan Brooks, et al.
Published: (2012-01-01)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
by: Arora N, et al.
Published: (2021-03-01)

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure
by: Liriye Kurtovic, et al.
Published: (2019-02-01)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
by: Daniel Ansong, et al.
Published: (2011-04-01)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
by: Seth Owusu-Agyei, et al.
Published: (2010-01-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
by: John N Waitumbi, et al.
Published: (2009-11-01)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
by: Stephaney Gyaase, et al.
Published: (2021-01-01)

Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
by: Mohammad Zeeshan, et al.
Published: (2012-01-01)

RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials
by: Machteld van den Berg, et al.
Published: (2019-05-01)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
by: Robert A. van den Berg, et al.
Published: (2017-05-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
by: Seth Owusu-Agyei, et al.
Published: (2009-10-01)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
by: Carlota Dobaño, et al.
Published: (2019-05-01)

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries
by: Christophe Sauboin, et al.
Published: (2019-12-01)

Correction: Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
by: Seth Owusu-Agyei, et al.
Published: (2010-01-01)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children
by: Lievens Marc, et al.
Published: (2011-08-01)

Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
by: Alexandra B Hogan, et al.
Published: (2020-11-01)

Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination
by: Carlota Dobaño, et al.
Published: (2019-03-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
by: John Lusingu, et al.
Published: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
by: John Lusingu, et al.
Published: (2010-11-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
by: John Lusingu, et al.
Published: (2010-01-01)

Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens.
by: Joseph J Campo, et al.
Published: (2011-01-01)

Assessment of humoral and cellular immune responses of the RTS,S/AS02D malaria vaccine candidate administered to infants living in a malaria endemic area in Mozambique
by: Aide, Pedro Carlos Paulino
Published: (2010)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
by: John Lusingu, et al.
Published: (2010-01-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
by: John Lusingu, et al.
Published: (2010-01-01)

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine
by: Carter Terrell, et al.
Published: (2011-08-01)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
by: Ally Olotu, et al.
Published: (2011-01-01)

A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.
by: Bertrand Lell, et al.
Published: (2009-10-01)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care
by: Vekemans Johan, et al.
Published: (2011-08-01)

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02<sub>D</sub> malaria vaccine in infants living in a malaria-endemic region
by: Abdulla Salim, et al.
Published: (2013-01-01)

Baseline incidence of meningitis, malaria, mortality and other health outcomes in infants and young sub-Saharan African children prior to the introduction of the RTS,S/AS01E malaria vaccine
by: The RTS,S Epidemiology EPI-MAL-002 Study Group
Published: (2021-04-01)

RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial
by: Gemma Moncunill, et al.
Published: (2017-08-01)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
by: Mark E Polhemus, et al.
Published: (2009-07-01)

Immunopotentiation of malaria vaccines
by: Russell, Clare
Published: (2004)